Comorbidity and age affect treatment policy for cervical cancer: A population-based study in the south of the Netherlands, 1995-2004

European Journal of Gynaecological Oncology

Volumn 29, Issue 5, 2008, Pages 493-498

  van der Aa, M A ^a   Siesling, S ^a   Kruitwagen, R F P M ^b,c   Lybeert, M L M ^d   Coebergh, J W W ^e,f   Janssen Heijnen, M L G ^b  

^a Integraal Kankercentrum Stedendriehoek Twente   (Netherlands)

^b CPRLab   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d CATHARINA HOSPITAL   (Netherlands)

^e The Netherlands   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cervical cancer; Chemoradiation; Comorbidity; Radical hysterectomy; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; HYPERTHERMIC THERAPY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MULTIMODALITY CANCER THERAPY; NETHERLANDS; POLICY; POPULATION RESEARCH; PROGNOSIS; RADICAL HYSTERECTOMY; UTERINE CERVIX CANCER;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 54949118671     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Comprehensive Cancer Centres. http://www.ikcnet.nl/. retrieved 6-2-2007.
2. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V. et al.: "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide". J. Pathol., 1999, 189, 12.
3. Franco E.L., Duarte-Franco E., Ferenczy A.: "Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection". CMAJ, 2001, 164, 1017.
4. Plummer M., Herrero R., Franceschi S., Meijer C.J., Snijders P., Bosch F.X. et al.: "Smoking and cervical cancer: pooled analysis of the IARC multi-centric case - control study". Cancer Causes Control, 2003, 14, 805.
5. Trimbos J.B.: "Gynaecologische Oncologieklapper". 2nd ed. Leiden, the Netherlands: Working Group for Gynecological Oncology; 1995.
6. Morris M., Eifel P.J., Lu J., Grigsby P.W., Levenback C., Stevens R.E. et al.: "Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer". N. Engl. J. Med., 1999, 340, 1137.
7. Whitney C.W., Sause W., Bundy B.N., Malfetano J.H., Hannigan E.V., Fowler W.C. Jr., et al.: "Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in Stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study". J. Clin. Oncol., 1999, 17, 1339.
8. Keys H.M., Bundy B.N., Stehman F.B., Muderspach L.I., Chafe W.E., Suggs C.L. III, et al.: "Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky Stage IB cervical carcinoma". N. Engl. J. Med., 1999, 340, 1154.
9. Peters W.A. III, Liu P.Y., Barrett R.J., Stock R.J., Monk B.J., Berek J.S. et al.: "Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix". J. Clin. Oncol., 2000, 18, 1606-.
10. Rose P.G., Bundy B.N., Watkins E.B., Thigpen J.T., Deppe G., Maiman M.A. et al.: "Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer". N. Engl. J. Med., 1999, 340, 1144.
11. van der Zee J., Gonzalez G.D.: "The Dutch Deep Hyperthermia Trial: results in cervical cancer". Int. J. Hyperthermia, 2002, 18, 1.
12. Working Group Gynaecologic Oncology. http://www.oncoline.nl. retrieved 2007.
13. Brooks S.E., Chen T.T., Ghosh A., Mullins C.D., Gardner J.F., Baquet C.R.: "Cervical cancer outcomes analysis: impact of age, race, and comorbid illness on hospitalizations for invasive carcinoma of the cervix". Gynecol. Oncol., 2000, 79, 107.
14. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R.: "A new method of classifying prognostic comorbidity in longitudinal studies: development and validation". J. Chronic. Dis., 1987, 40, 373.
15. Hermanek P., Hutter R., Sobin L., Wagner G., Wittekind C. (eds.). TNM Atlas. 4th edition, Berlin, UICC, Springer-Verlag, 1997.
16. Ederer F., Axtell L.M., Cutler S.J.: "The relative survival rate: a statistical methodology". Natl. Cancer Inst. Monogr., 1961, 6, 101.
17. Yamashita H., Nakagawa K., Tago M., Shiraishi K., Nakamura N., Ohtomo K. et al.: "Comparison between conventional surgery and radiotherapy for FIGO Stage I-II cervical carcinoma: a retrospective Japanese study". Gynecol. Oncol., 2005, 97, 834.
18. Landoni F., Maneo A., Colombo A., Placa F., Milani R., Perego P., et al.: "Randomised study of radical surgery versus radiotherapy for Stage Ib-IIa cervical cancer". Lancet, 1997, 350, 535.
19. Goodheart M., Jacobson G., Smith B.J., Thou L.: "Chemoradiation for invasive cervical cancer in elderly patients: outcomes and morbidity". Int. J. Gynecol. Cancer, 2008, 26, 95.
20. Wright J.D., Gibb R.K., Geevarghese S., Powell M.A., Herzog T.J., Mutch D.G. et al.: "Cervical carcinoma in the elderly: an analysis of patterns of care and outcome". Cancer, 2005, 103, 85.
21. Yellen S.B., Celia D.F., Leslie W.T.: "Age and clinical decision making in oncology patients". J. Natl. Cancer Inst., 1994, 86, 1766.
22. Newcomb P.A., Carbone P.P.: "Cancer treatment and age: patient perspectives". J. Natl. Cancer Inst., 1993, 85, 1580.
23. Monk B.J., Tian C., Rose P.G., Lanciano R.: "Which clinical/ pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trials". Gynecol. Oncol., 2007, 105, 427.
24. Houterman S., Verheij C.D.G.W., Jansen-Heijnen M.L.G. et al.: "Validation study on comorbidity in women with breast cancer diagnosed between 1995 and 1999 (internal report)". Eindhoven: Eindhoven Cancer Registry, 2003.
25. Signaleringscommissie Kanker van K.W.F. Kankerbestrijding. Kanker in Nederland; Trends, prognoses en imphicaties voor zorgvraag. Oisterwijk: Drukkerij van den Boogaard, 2004.